Turk, S. Et Al. 2019. Determination of drug sensitivity subgroups in acute myeloblastic leukemia by the detection of gene-based cancer biomarkers and the prediction of prognosis and treatment. FEBS OPEN BIO , vol.9 , 324.

Turk, S., Ghasemi, M., Akbar, M. W., Okay, M., Erikci, A., SAYINALP, N., ... Haznedaroglu, I. C.(2019). Determination of drug sensitivity subgroups in acute myeloblastic leukemia by the detection of gene-based cancer biomarkers and the prediction of prognosis and treatment. FEBS OPEN BIO , vol.9, 324.

Turk, S. Et Al. "Determination of drug sensitivity subgroups in acute myeloblastic leukemia by the detection of gene-based cancer biomarkers and the prediction of prognosis and treatment," FEBS OPEN BIO , vol.9, 324, 2019

Turk, S. Et Al. "Determination of drug sensitivity subgroups in acute myeloblastic leukemia by the detection of gene-based cancer biomarkers and the prediction of prognosis and treatment." FEBS OPEN BIO , vol.9, pp.324, 2019

Turk, S. Et Al. (2019) . "Determination of drug sensitivity subgroups in acute myeloblastic leukemia by the detection of gene-based cancer biomarkers and the prediction of prognosis and treatment." FEBS OPEN BIO , vol.9, p.324.

@article{article, author={S. Turk Et Al. }, title={Determination of drug sensitivity subgroups in acute myeloblastic leukemia by the detection of gene-based cancer biomarkers and the prediction of prognosis and treatment}, journal={FEBS OPEN BIO}, year=2019, pages={324} }